✦ LIBER ✦

Quality of life assessment during clinical trials: Application to the multicentre phase II study of fotemustine in advanced non small cell lung carcinoma (NSCLC)

✍ Scribed by Berille, J.; Ressayre, C.; Pujol, J.L.; Monnier, A.; Douillard, J.Y.; Cerrina, M.L.; Gouva, S.; Le Groumellec, A.; Le Chevalier, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial assessing the combination

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Quality of life (QL) assessment in a mul

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Gemcitabine monotherapy in the elderly p

✍ Antonuzzo, A; Galli, L; Ricci, S; Tibaldi, C; Bertuccelli, M; Petruzzelli, S; Ta 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase II study of gemcitabine plus cis

✍ Jassem, Jacek; Krzakowski, Maciej; Roszkowski, Kazimierz; Ramlau, Rodryg; Marek 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

PD-069 Quality-of-Life (COL) assessment

✍ Camps, C.; Massuti, B.; Jiménez, A.; Maestu, I.; Garcia, R.; Isla, M.; González- 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Phase II trial and cost analysis of faza

✍ Stephen K. Williamson; John J. Crowley; Robert B. Livingston; Timothy J. Panella 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 372 KB